Assignee
TURNER SEAN COLM
DE·7 granted patents·2 pending applications·49 citations·filing 2008–2012
Top patents by PatentIndex Score
9 records- 0188US9090592B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Jul 28, 2015·6 cites·29 claims
- 0288US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 0388US8318793B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2010·Granted Nov 27, 2012·17 cites·19 claims
- 0486US9266855B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Feb 23, 2016·11 cites·22 claims
- 0574US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 0671US8455648B21-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)TURNER SEAN COLM·Filed 2009·Granted Jun 4, 2013·1 cites·19 claims
- 0761US2010210664A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2008·Application pending·0 cites
- 0858US8293913B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Oct 23, 2012·0 cites·13 claims
- 0953US2011319421A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TURNER SEAN COLM files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →